ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 36 filers reported holding ANI PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,028,000 | +2.1% | 214,908 | +11.7% | 0.00% | 0.0% |
| Q3 2016 | $12,762,000 | +20.9% | 192,339 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $10,560,000 | +64.3% | 189,176 | -1.0% | 0.00% | +100.0% |
| Q1 2016 | $6,429,000 | -25.6% | 191,007 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $8,636,000 | +16.8% | 191,383 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $7,393,000 | -51.9% | 187,114 | -24.5% | 0.00% | -50.0% |
| Q2 2015 | $15,386,000 | +0.4% | 247,959 | +1.2% | 0.00% | 0.0% |
| Q1 2015 | $15,323,000 | +11.4% | 244,966 | +0.4% | 0.00% | 0.0% |
| Q4 2014 | $13,758,000 | +48.2% | 243,972 | -25.7% | 0.00% | 0.0% |
| Q3 2014 | $9,281,000 | -5.2% | 328,186 | +15.4% | 0.00% | 0.0% |
| Q2 2014 | $9,793,000 | +39.1% | 284,336 | +26.7% | 0.00% | +100.0% |
| Q1 2014 | $7,038,000 | +50.4% | 224,497 | -3.7% | 0.00% | 0.0% |
| Q4 2013 | $4,680,000 | +116.1% | 233,067 | +5.1% | 0.00% | – |
| Q3 2013 | $2,166,000 | – | 221,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
| Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
| Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
| MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
| EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
| Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
| Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |